Average Co-Inventor Count = 10.33
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (14 from 2,405 patents)
2. Other (1 from 832,880 patents)
3. Metabasis Therapeutics, Inc. (1 from 64 patents)
4. Merck Shapr & Dohme Corp. (1 from 1 patent)
16 patents:
1. 11820805 - Conjugate based systems for controlled insulin delivery
2. 11530250 - Tyrosine-specific functionalized insulin and insulin analogs
3. 11041009 - Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
4. 10800827 - Insulin receptor partial agonists
5. 10689430 - Insulin receptor partial agonists
6. 10183981 - Insulin receptor partial agonists
7. 10017556 - Insulin receptor partial agonists
8. 9868733 - Azabenzimidazole tetrahydrofuran derivatives
9. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives
10. 9540364 - Benzimidazole tetrahydrofuran derivatives
11. 9527839 - Benzimidazole tetrahydropyran derivatives
12. 9382243 - Azabenzimidazole tetrahydropyran derivatives
13. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
14. 8895596 - Cyclic benzimidazole derivatives useful as anti-diabetic agents
15. 8410284 - Cyclic benzimidazole derivatives useful as anti-diabetic agents